|
Activities, Bill Numbers and Titles
|
|
|
|
Senate Bill
|
2409
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$1,673.00
|
N/A
|
|
Senate Bill
|
606
|
An Act promoting continuity of care for multiple sclerosis treatment
|
Support
|
$418.00
|
N/A
|
|
House Bill
|
916
|
An Act relative to co-pay assistance
|
Support
|
$836.50
|
N/A
|
|
Senate Bill
|
541
|
An Act relative to co-pay assistance
|
Support
|
$836.50
|
N/A
|
|
House Bill
|
1133
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$836.50
|
N/A
|
|
Senate Bill
|
1206
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$418.00
|
N/A
|
|
House Bill
|
4134
|
An Act to improve health care by investing in VALUE
|
Oppose
|
$1,673.00
|
N/A
|
|
House Bill
|
3481
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$418.00
|
N/A
|
|
House Bill
|
3556
|
An Act promoting continuity of care for multiple sclerosis treatment
|
Support
|
$418.00
|
N/A
|
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$836.50
|
N/A
|
| | | |
Total amount
|
$8,364.00
| |
|
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|